- Home
- MOGO vs AEON Comparison
MOGO vs AEON Comparison
Compare MOGO & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- AEON
- Stock Information
- Founded
- MOGO 2003
- AEON N/A
- Country
- MOGO Canada
- AEON United States
- Employees
- MOGO N/A
- AEON N/A
- Industry
- MOGO
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- AEON Health Care
- Exchange
- MOGO Nasdaq
- AEON Nasdaq
- Market Cap
- MOGO 25.1M
- AEON 4.2M
- IPO Year
- MOGO N/A
- AEON N/A
- Fundamental
- Price
- MOGO $1.07
- AEON $0.46
- Analyst Decision
- MOGO Strong Buy
- AEON Strong Buy
- Analyst Count
- MOGO 1
- AEON 1
- Target Price
- MOGO $4.00
- AEON $360.00
- AVG Volume (30 Days)
- MOGO 100.0K
- AEON 301.1K
- Earning Date
- MOGO 05-08-2025
- AEON 05-16-2025
- Dividend Yield
- MOGO N/A
- AEON N/A
- EPS Growth
- MOGO N/A
- AEON N/A
- EPS
- MOGO N/A
- AEON 72.93
- Revenue
- MOGO $28,931,019.00
- AEON N/A
- Revenue This Year
- MOGO $59.16
- AEON N/A
- Revenue Next Year
- MOGO $6.17
- AEON N/A
- P/E Ratio
- MOGO N/A
- AEON $0.01
- Revenue Growth
- MOGO N/A
- AEON N/A
- 52 Week Low
- MOGO $0.74
- AEON $0.38
- 52 Week High
- MOGO $1.95
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- MOGO 55.58
- AEON 31.93
- Support Level
- MOGO $1.05
- AEON $0.39
- Resistance Level
- MOGO $1.32
- AEON $0.57
- Average True Range (ATR)
- MOGO 0.12
- AEON 0.04
- MACD
- MOGO 0.02
- AEON 0.11
- Stochastic Oscillator
- MOGO 50.96
- AEON 41.71
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.